Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Blois
Clinical trial register · France

Clinical Trials in Blois, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9731 matching records held by the registry are in this view. Synced 02 Nov 2026, 03:18 UTC
9731
Studies in scope
all four open statuses
6052
Recruiting now
open to new participants
1028
Lead sponsors
across recruiting studies
Top sites
Paris 2829 Lyon 1396 Bordeaux 1393 Marseille 1295 Lille 1283
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Hospital, Tours8 UNICANCER3 Intergroupe Francophone du Myelome2 AstraZeneca2 French Innovative Leukemia Organisation2
Site location
Paris2829 Lyon1396 Bordeaux1393 Marseille1295 Lille1283
All 804 locations
Target enrolment
to

Trials with a site in Blois

30 of 9731 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Not yet open
Outcome of Patients With Severe Mental Illness in the Intensive Care Unit
NCT07705802Severe Mental Illness, Severe Mental Disorder
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Observational
2,000
Nice, La Rochelle, Quincy-sous-Sénart, Boulogne-Billancourt, Rennes, Blois, Cahors, Vannes
2026-09
Recruiting
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
NCT07106632Early Breast Cancer, Premenopausal Breast Cancer, HR+/HER2- Breast Cancer
UNICANCER
Phase 3
3,380
Auxerre, Avignon, Bayonne, Beauvais, Blois, Bobigny, Bordeaux, Bourg-en-Bresse
2026-06-26
Not yet open
Inhaled Amikacin Versus Placebo in Patients With Ventilator-associated Tracheobronchitis
NCT07665788Ventilator-Associated Pneumonia, Ventilator-Associated Tracheobronchitis
University Hospital, Tours
Phase 3
250
Angers, Argenteuil, Blois, Bourg-en-Bresse, Créteil, Dieppe, Dijon, Dreux
2026-06-01
Recruiting
Assistance Publique - Hôpitaux de Paris
Phase 2
30
Blois, Bondy, Bordeaux, Caen, Clermont-Ferrand, Créteil, Dijon, Le Kremlin-Bicêtre
2026-01-30
Recruiting
Sanofi
Observational
500
Aix-en-Provence, Antibes, Blois, Brest, Colmar, Contamine-sur-Arve, Évreux, La Tronche
2026-01-28
Recruiting
University Hospital, Tours
Not applicable
1,078
Amiens, Angers, Argenteuil, Belfort, Besançon, Béthune, Blois, Bordeaux
2025-11-30
Recruiting
UNICANCER
Phase 2
80
Amiens, Auxerre, Avignon, Bayonne, Beauvais, Beuvry, Blois, Boulogne-sur-Mer
2025-07-30
Recruiting
Intergroupe Francophone du Myelome
Phase 3
824
Amiens, Angers, Annecy, Argenteuil, Avignon, Bayonne, Besançon, Blois
2025-07-09
Recruiting
GlaxoSmithKline
Phase 3
981
Saint-Quentin, Marseille, Amiens, Blois, Caen, La Tronche, Lyon, Nice
2025-06-20
Not yet open
University Hospital, Tours
Not applicable
332
Angers, Blois, Brest, Nantes, Tours
2025-03
Recruiting
Non-inferiority of Continuing Oral Intake Versus Fasting in Patients With Acute Respiratory Failure
NCT06510972Respiratory Insufficiency, Fasting, Dysphagia, Swallowing Disorder
University Hospital, Tours
Not applicable
754
Blois, Bourges, Colombes, Dreux, La Roche-sur-Yon, Le Mans, Lille, Morlaix
2025-02-05
Not yet open
Groupe français d'étude des Maladies Inflammatoires de loeil
Observational
80
Aix-en-Provence, Blois, Caen, Le Mans, Marseille, Melun, Montfermeil, Nantes
2025-01-15
Recruiting
UmbREALung - A Retrospective and Prospective, Observational, Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
NCT06726720Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
AstraZeneca
Observational
300
Aix-en-Provence, Angers, Aurillac, Auxerre, Avignon, Bezannes, Béziers, Blois
2024-12-16
Not yet open
University Hospital, Tours
Phase 3
546
Angers, Blois, Chartres, Nantes, Orléans, Poitiers, Tours
2024-04
Recruiting
AstraZeneca
Phase 3
5,250
Aix-en-Provence, Aurillac, Bayonne, Biarritz, Blois, Brest, Cannes, Cherbourg
2024-02-21
Recruiting
Weaning Protocol for High-flow Nasal Oxygen Therapy in Intensive Care
NCT06104956Acute Hypoxemic Respiratory Failure, High-flow Nasal Oxygen Therapy
University Hospital, Tours
Not applicable
370
Blois, Bourg-en-Bresse, Bourges, Caen, Chartres, Cholet, Dax, Le Mans
2024-02-17
Recruiting
Nantes University Hospital
Observational
700
Besançon, Brest, Angers, Blois, Bordeaux, Dijon, Grenoble, La Rochelle
2023-07-24
Active, closed
Novartis Pharmaceuticals
Phase 3
152
Blois, Le Mans
2023-02-02
Active, closed
French Innovative Leukemia Organisation
Observational
1,000
Amiens, Angers, Annecy, Argenteuil, Avignon, Besançon, Béziers, Blois
2022-11-11
Recruiting
University Hospital, Tours
Not applicable
338
Blois, Brest, Chambray-lès-Tours, Châteauroux, Le Mans, Orléans, Saint-Benoît-la-Forêt, Tours
2022-06-23
Recruiting
University Hospital, Tours
Not applicable
200
Blois, Chinon, Dreux, Fleury-les-Aubrais, La Roche-sur-Yon, Neuilly-sur-Marne, Rennes, Saint-Maurice
2022-06-17
Active, closed
SOLTI Breast Cancer Research Group
Phase 2
1,100
Avignon, Bayonne, Besançon, Blois, Caen, Cholet, Clermont-Ferrand, Dijon
2022-05-03
Recruiting
Royal Marsden NHS Foundation Trust
Phase 2
1,100
Angers, Annecy, Avignon, Blois, Bordeaux, Clermont-Ferrand, Dijon, Grenoble
2022-03-30
Active, closed
Intergroupe Francophone du Myelome
Phase 3
791
Amiens, Angers, Argenteuil, Avignon, Bayonne, Besançon, Blois, Bobigny
2021-12-08
Recruiting
University Hospital, Lille
Observational
1,500
Amiens, Annecy, Besançon, Blois, Bobigny, Bordeaux, Boulogne-Billancourt, Caen
2021-07-09
Active, closed
French Innovative Leukemia Organisation
Phase 2
82
Amiens, Angers, Annecy, Bayonne, Besançon, Béziers, Blois, Bordeaux
2019-05-22
Active, closed
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer
NCT03774732Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma of Lung, TNM Stage 4
DrugPembrolizumab
UNICANCER
Phase 3
327
Angers, Arras, Avignon, Beuvry, Blois, Bordeaux, Brest, Caen
2018-01-24
Active, closed
Bristol-Myers Squibb
Observational
2,555
Blois, Chalon-sur-Saône, La Roche-sur-Yon, Limoges, Meaux, Nantes, Rennes
2012-06-13
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
DrugsTamoxifen Citrate·Tamoxifen·Exemestane·Anastrozole
National Cancer Institute (NCI)
Phase 3
5,018
Angers, Auch, Avignon, Bayonne, Beauvais, Blois, Bordeaux, Brest
2011-02-28
Recruiting
Esteve Pharmaceuticals, S.A.
Observational
500
Amiens, Blois, Bondy, Bron, Clermont-Ferrand, Marseille, Montpellier, Mulhouse
2008-12-09
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 4 November 2026. https://priyalifescience.com/clinical-trials-france/city/blois

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,731 studies in total at the last sync on 02 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Blois.

How many clinical trials are recruiting in Blois?

17 of the 30 studies on this page are recruiting new participants as of the 02 Nov 2026, 03:18 UTC sync. A further 5 have not yet opened recruitment, 8 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Blois), 30 studies
PhaseStudiesRecruitingShare
Phase 310433.3%
Observational9530%
Not applicable6520%
Phase 25316.7%

Most active sponsors

Lead sponsors with the most studies (Blois)
Lead sponsorStudiesRecruiting
University Hospital, Tours85
UNICANCER32
AstraZeneca22
French Innovative Leukemia Organisation20
Intergroupe Francophone du Myelome21
Assistance Publique - Hôpitaux de Paris11
Bristol-Myers Squibb10
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer10
Esteve Pharmaceuticals, S.A.11
GlaxoSmithKline11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.